Int J Obes (Lond) · 2014
The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic optionsConclusion: Almost all studies are in the preclinical phase. There are currently no effective clinical treatments for MC4R-deficient obese patients, although MC4R agonists are being developed and are entering phase I and II trials.